Your browser doesn't support javascript.
loading
Risk for second primary cancers among pediatric and young adult melanoma survivors.
Luu, Yen; Han, Joseph; Agarwal, Aneesh; Elkady, Nadine; Jaroonwanichkul, Sandra; Gulati, Nicholas; Gittler, Julia.
Afiliação
  • Luu Y; Department of Dermatology, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA.
  • Han J; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York City, New York, USA.
  • Agarwal A; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York City, New York, USA.
  • Elkady N; Department of Dermatology, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA.
  • Jaroonwanichkul S; Department of Dermatology, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA.
  • Gulati N; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York City, New York, USA.
  • Gittler J; Department of Medicine, Division of Dermatology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, USA.
Pediatr Dermatol ; 41(1): 12-15, 2024.
Article em En | MEDLINE | ID: mdl-37776000
ABSTRACT
BACKGROUND/

OBJECTIVES:

Second primary cancers (SPCs) are a leading cause of morbidity and mortality among cancer survivors. In this study, we aimed to characterize the incidence of SPCs among pediatric and young adult survivors of CM.

METHODS:

Using the Surveillance, Epidemiology, and End Results Program data spanning 2000-2018, we calculated standardized incidence ratios (SIR) to assess SPC risk in all pediatric (0-18 years) and young adult (19-29 years) patients with a first primary cancer diagnosis of CM.

RESULTS:

Of 7,169 total CM survivors, 632 (8.82%) developed a SPC, corresponding to a 5-fold increased risk (standardized incidence ratio [SIR] 4.98; 95% confidence interval [CI] 4.60-5.38) compared to the general population. There was a highly elevated risk for second primary melanoma across all age groups (SIR 32.5; 95% CI 29.7-35.6), constituting the majority of SPC diagnoses (N = 485). Infants diagnosed with CM before 1 year of age had the highest risk for any SPC (SIR 164; 95% CI 19.8-592) and young adults diagnosed at 25-29 years had the lowest risk (SIR 4.64; 95% CI 4.19-5.13). SPC incidence was highest within the first year of CM diagnosis (SIR 27.5; 95% CI 23.7-31.6) and progressively decreased with time.

CONCLUSIONS:

Variation exists in the incidence and type of SPC according to age among pediatric and young adult survivors of CM.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Segunda Neoplasia Primária / Sobreviventes de Câncer / Melanoma Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adult / Child / Humans / Infant Idioma: En Revista: Pediatr Dermatol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Segunda Neoplasia Primária / Sobreviventes de Câncer / Melanoma Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adult / Child / Humans / Infant Idioma: En Revista: Pediatr Dermatol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos